Check the latest and revised syllabus for the CBSE board class 10th other subjects. Check the details below: Step 2: Click on the section labelled “Curriculum.” Step 3: Click on the link or tab ...

Bihar Board Model Papers PDF: The Bihar School Examination Board (BSEB) conducts the annual Class 10 and Class 12 board examinations in the state. To support students in preparing for the upcoming ...

*Estimated payments are calculated by Cars.com and are for informational purposes only. We’ve estimated your taxes based on your provided ZIP code. These estimates do not include title, registration ...

The updated AFC playoff picture isn't looking favorable for the Cincinnati Bengals as they prepare for their final four games of the season. The Bills hurt the Bengals' playoff chances by rallying ...

Ola Electric shares: Electric vehicle manufacturer Ola Electric Mobility saw a strong buying interest, hitting an upper circuit, on Friday as the beleaguered two-wheeler maker said the selling ...

Ola Electric Mobility’s founder and Chief Executive Officer Bhavish Aggarwal on Tuesday, December 16, 2025, sold over 2.62 crore equity shares of the company through a bulk deal, according to data ...

Indian equity benchmark indices, the Sensex and the Nifty, corrected sharply on Tuesday. While Nifty ended 167 points lower, the Sensex was down by 522 points. The fall comes as the rupee breached the ...

James Chen, CMT is an expert trader, investment adviser, and global market strategist. Khadija Khartit is a strategy, investment, and funding expert, and an educator of fintech and strategic finance ...

Vedanta Group chairman Anil Agarwal has hailed silver's exceptional price surge this year, pointing out that the metal's remarkable rise in value is driven by both intrinsic value and functional ...

ImmunityBio, Inc. (NASDAQ: IBRX), a leading immunotherapy company, today announced treatment with ANKTIVA® (nogapendekin alfa inbakicept-pmln) plus Bacillus Calmette-Guérin (BCG) demonstrates efficacy ...

Enzomenib was escalated from 40 mg twice a day (BID) to 400 mg BID with no dose-limiting toxicities (DLTs). Treatment-related adverse events (TRAEs) observed in at least 10% of patients were nausea ...